-
1
-
2
-
3
-
4
Filaggrin in atopic dermatitis
Veröffentlicht in Journal of allergy and clinical immunology
VolltextArtikel -
5
Antimicrobial peptides and the skin immune defense system
Veröffentlicht in Journal of allergy and clinical immunology
VolltextArtikel -
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease: VAN SCHALKWYK E, STRYDOM K, WILLIAMS Z et al. : Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions. J. Allergy Clin. Immunol. (2005) 116 :292-298 and RABE KE, BATEMAN ED, O’DONNELL D et al. : Ro
Veröffentlicht in Expert opinion on pharmacotherapy
VolltextArtikel -
14
Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease: VAN SCHALKWYK E, STRYDOM K, WILLIAMS Z et al.: Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions. J. Allergy Clin. Immunol. (2005) 116:292-298 and RABE KE, BATEMAN ED, O'DONNELL D et al.: Roflumilast - an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet (2005) 366:563-571
Veröffentlicht in Expert opinion on pharmacotherapy
VolltextArtikel -
15
-
16
-
17
-
18
-
19
-
20